Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jennie Young"'
Autor:
Kellen Cristina da Cruz Rodrigues, Seung Chan Kim, Aaron Aykut Uner, Zhi-Shuai Hou, Jennie Young, Clara Campolim, Ahmet Aydogan, Brendon Chung, Anthony Choi, Won-Mo Yang, Woojin S. Kim, Vincent Prevot, Barbara J. Caldarone, Hyon Lee, Young-Bum Kim
Publikováno v:
Molecular Metabolism, Vol 84, Iss , Pp 101941- (2024)
Objective: Low-density lipoprotein receptor-related protein-1 (LRP1) regulates energy homeostasis, blood–brain barrier integrity, and metabolic signaling in the brain. Deficiency of LRP1 in inhibitory gamma-aminobutyric acid (GABA)ergic neurons cau
Externí odkaz:
https://doaj.org/article/e55f3e4f47234ed2a72826ad4425a226
Autor:
Sally Wheelwright, Lucy Matthews, Valerie Jenkins, Shirley May, Daniel Rea, Pat Fairbrother, Claire Gaunt, Jennie Young, Sarah Pirrie, Matthew G. Wallis, Lesley Fallowfield, on behalf of the LORIS Trial Management Group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background The LOw RISk DCIS (LORIS) study was set up to compare conventional surgical treatment with active monitoring in women with ductal carcinoma in situ (DCIS). Recruitment to trials with a surveillance arm is known to be challenging,
Externí odkaz:
https://doaj.org/article/503fbba1f83546d5b5e97ab96d86990c
Autor:
Aaron Aykut Uner, Zhi-Shuai Hou, Ahmet Aydogan, Kellen Cristina da Cruz Rodrigues, Jennie Young, Anthony Choi, Won-Mo Yang, Jongkyun Kang, Woojin Kim, Vincent Prevot, Barbara J Caldarone, Hyon Lee, Young-Bum Kim
Low-density lipoprotein receptor-related protein-1 (LRP1) plays an important role in regulating energy homeostasis, the integrity of the blood-brain barrier, and metabolic signal transport across the brain, while its dysfunction has been associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd8340bef7457b2dac097f68b1f027ca
https://doi.org/10.1101/2022.09.17.508390
https://doi.org/10.1101/2022.09.17.508390
Autor:
Jennie Young
Publikováno v:
Our Body of Work: Embodied Administration and Teaching ISBN: 9781646422333
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205f02c3fead517c310209c66e2165ca
https://doi.org/10.7330/9781646422340.c006.2
https://doi.org/10.7330/9781646422340.c006.2
Autor:
John Crown, David Dodwell, Helena M. Earl, S O'Reilly, Jean Abraham, James Carmichael, Andrew Goodman, Peter Canney, Daniel Rea, Karen McAdam, A. Bowman, David Cameron, Janet A. Dunn, Michelle McDermaid, Robert C. F. Leonard, Helen Howard, Elena Provenzano, Sarah Bowden, Diana Ritchie, R.K. Agrawal, Andrew M Wardley, Christopher J. Poole, Anna Waterhouse, M. John Kennedy, Carlos Caldas, Gregory C. Wilson, Tamas Hickish, Jennie Young, Robert E. Coleman, Louise Hiller
Publikováno v:
Earl, H M, Hiller, L, Howard, H C, Dunn, J A, Young, J, Bowden, S J, McDermaid, M, Waterhouse, A K, Wilson, G, Agrawal, R, O'Reilly, S, Bowman, A, Ritchie, D M, Goodman, A, Hickish, T, McAdam, K, Cameron, D, Dodwell, D, Rea, D W, Caldas, C, Provenzano, E, Abraham, J E, Canney, P, Crown, J P, Kennedy, M J, Coleman, R, Leonard, R C, Carmichael, J A & Wardley, A M & Poole, C J 2017, ' Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo) : final 10-year follow-up of an open-label, randomised, phase 3 trial ', The Lancet Oncology . https://doi.org/10.1016/S1470-2045(17)30319-4
Background:\ud The tAnGo trial was designed to investigate the potential role of gemcitabine when added to anthracycline and taxane-containing adjuvant chemotherapy for early breast cancer. When this study was developed, gemcitabine had shown signifi
Autor:
Valerie Jenkins, Matthew G. Wallis, Cassandra Brookes, Malcolm W.R. Reed, Jeremy Thomas, Claire Gaunt, Jennie Young, Adele Francis, Patricia Fairbrother, Sarah Bowden, Sarah Pirrie, Lesley Fallowfield, Daniel Rea, John M. S. Bartlett, David Dodwell, L. Matthews, Tracy E Roberts, Sarah E Pinder, Cliona C. Kirwan, Andrew M. Hanby, Margaret Wilcox, Andrew Evans, Lucinda Billingham
Publikováno v:
Annals of Surgical Oncology. 24:566-567
Autor:
Jeremy Thomas, Jennie Young, Tracy E Roberts, Andrew Evans, Daniel Rea, John M. S. Bartlett, Andrew M. Hanby, Malcolm W.R. Reed, David Dodwell, Sarah Bowden, Sarah E Pinder, Maggie Wilcox, Valerie Jenkins, Cassandra Brookes, L. Matthews, Lucinda Billingham, Sarah Pirrie, Lesley Fallowfield, Adele Francis, Patricia Fairbrother, Matthew G. Wallis, Claire Gaunt
Publikováno v:
European journal of cancer (Oxford, England : 1990). 51(16)
Overdiagnosis, and thus overtreatment, are inevitable consequences of most screening programmes; identification of ways of minimising the impact of overdiagnosis demands new prospective research, in particular the need to separate clinically relevant
Autor:
Jennie Young
Publikováno v:
Writing on the Edge; Fall2018, Vol. 29 Issue 1, p59-70, 12p
Autor:
Jennie Young, Kerrie Dougherty
Publikováno v:
57th International Astronautical Congress.
Autor:
Tamas Hickish, Luke Hughes-Davies, Jennie Young, Gordon C. Wishart, Anne-Laure Vallier, Ioannis Gounaris, Anthony Skene, Susan Dean, Carlos Caldas, Mahesh Iddawela, Janet A. Dunn, Stephen Houston, Robert W. Laing, Elena Provenzano, Helena M. Earl, Louise Hiller, Karen McAdam, Mark Harries, Stephen Chan, Jean Abraham, Nicola Fenwick, J. Christopher Gallagher, Diana Ritchie
Publikováno v:
The Lancet Oncology. (2):201-212
SummaryBackgroundAnthracyclines and taxanes have been the standard neoadjuvant chemotherapies for breast cancer in the past decade. We aimed to assess safety and efficacy of the addition of gemcitabine to accelerated paclitaxel with epirubicin and cy